Degree of cardiac fibrosis and hypertrophy at time of implantation predicts myocardial improvement during left ventricular assist device support
- PMID: 14734125
- DOI: 10.1016/s1053-2498(03)00103-7
Degree of cardiac fibrosis and hypertrophy at time of implantation predicts myocardial improvement during left ventricular assist device support
Abstract
Background: There have been increasing reports of cardiac improvement in heart failure patients supported by left ventricular assist devices (LVADs i.e.), including a number of patients who have tolerated removal of the device without the benefit of cardiac transplant. In the current study, we retrospectively investigated echocardiographic and histologic changes in patients supported by LVADs (n = 18). The goal of our study was to determine if the degree of cardiac fibrosis and myocyte size in pre-implant biopsies could predict myocardial improvement as assessed by improvements in ejection fraction (EF) during LVAD support.
Methods: We determined total collagen content in myocardial biopsy specimens by a semi-quantitative analysis of positive Picro-Sirius Red-stained areas and myocyte size measurements by computerized edge detection software.
Results: During LVAD support, 9 of the 18 patients (Group A) were distinguished by significant improvement in ejection fraction (pre <20% vs unloaded 34 +/- 5%). In addition, Group A patients had significantly less fibrosis and smaller myocytes than their Group B counterparts, whose EF did not improve. There was an inverse correlation between pre-implant biopsy collagen levels and myocyte size with increases in EF during LVAD unloading.
Conclusions: We found that the patients who demonstrated the greatest improvements in EF during support had less fibrosis and smaller myocytes at the time of device implantation. We propose that tissue profiling a patient's pre-implant biopsy for fibrosis and myocyte size may allow stratification in Stage IV heart failure and may predict myocardial improvement during LVAD support.
Similar articles
-
Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist.J Heart Lung Transplant. 2010 Jun;29(6):672-9. doi: 10.1016/j.healun.2010.01.007. Epub 2010 Feb 25. J Heart Lung Transplant. 2010. PMID: 20188595
-
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.Circulation. 2007 May 15;115(19):2497-505. doi: 10.1161/CIRCULATIONAHA.106.633180. Epub 2007 May 7. Circulation. 2007. PMID: 17485581 Clinical Trial.
-
Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation.J Heart Lung Transplant. 2003 Feb;22(2):137-46. doi: 10.1016/s1053-2498(02)00485-0. J Heart Lung Transplant. 2003. PMID: 12581761
-
Granulomatous myocarditis in severe heart failure patients undergoing implantation of a left ventricular assist device.Cardiovasc Pathol. 2014 Jan-Feb;23(1):17-20. doi: 10.1016/j.carpath.2013.06.005. Epub 2013 Aug 6. Cardiovasc Pathol. 2014. PMID: 23928368 Review.
-
Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action.Curr Opin Cardiol. 2011 May;26(3):245-55. doi: 10.1097/HCO.0b013e328345af13. Curr Opin Cardiol. 2011. PMID: 21451407 Free PMC article. Review.
Cited by
-
Embolized Hydrophilic Coating Polymers Found in Left Ventricular Assist Device Apical Core Specimen.JACC Case Rep. 2022 Jul 6;4(13):819-821. doi: 10.1016/j.jaccas.2022.03.035. eCollection 2022 Jul 6. JACC Case Rep. 2022. PMID: 35818595 Free PMC article.
-
Taking pressure off the heart: the ins and outs of atrophic remodelling.Cardiovasc Res. 2011 May 1;90(2):243-50. doi: 10.1093/cvr/cvr060. Epub 2011 Feb 25. Cardiovasc Res. 2011. PMID: 21354996 Free PMC article. Review.
-
The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly.Heart Fail Rev. 2012 Sep;17(4-5):615-33. doi: 10.1007/s10741-012-9300-8. Heart Fail Rev. 2012. PMID: 22258830 Review.
-
Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects.Circ Heart Fail. 2011 Mar;4(2):224-33. doi: 10.1161/CIRCHEARTFAILURE.110.959684. Circ Heart Fail. 2011. PMID: 21406678 Free PMC article. Review. No abstract available.
-
Pathological findings in cardiac apex removed during implantation of left ventricular assist devices (LVAD) are non-specific: 13-year-experience at a German Heart Center.Int J Clin Exp Pathol. 2014 Aug 15;7(9):5549-56. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25337196 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical